UPDATE : Friday, July 10, 2020
Pfizer wins Champix patent suit against 20 local generics makers by Jeong Sae-im 2019-12-20 16:28
Kolon appeals Invossa’s safety in pleading at court by Jeong Sae-im 2019-12-20 14:57
4 firms to offer up to 56 direct-to-consumer genetic testing services by Jeong Sae-im 2019-12-19 16:40
QuantaMatrix passes technology review for Kosdaq listing by Jeong Sae-im 2019-12-19 14:21
4 new botulinum toxins to undergo trials in crowded market by Jeong Sae-im 2019-12-18 15:29
Venture capital investment in biomedical sector to hit record this year by Jeong Sae-im 2019-12-17 14:20
Helixmith to clarify why gene therapy study had data error by Jeong Sae-im 2019-12-13 15:13
Yuhan to start phase-3 trial on lung cancer drug Lazertinib by Jeong Sae-im 2019-12-12 15:04
Aprogen, 1st Korean biotech firm to win unicorn status by Jeong Sae-im 2019-12-11 13:10
Samsung execs get jail term for destroying evidence by Jeong Sae-im 2019-12-10 11:43
SK Biopharm set to ensure superiority in antiepileptic drug by Jeong Sae-im 2019-12-04 16:18
Samyang Biopharm’s US subsidiary to work on new immunotherapy by Jeong Sae-im 2019-12-03 15:37
Alteogen inks licensing-out deal for SC injection formulation technology by Jeong Sae-im 2019-12-02 15:25
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan by Jeong Sae-im 2019-11-29 15:23
New Parkinson’s drug Ongentys lands on Korea by Jeong Sae-im 2019-11-28 14:52
Kolon Life Science’s research head arrested for false Invossa data by Jeong Sae-im 2019-11-28 11:18
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug by Jeong Sae-im 2019-11-27 18:24
Roche Diagnostics challenges IBM Watson with differentiated strategy in tailor-made treatment market by Jeong Sae-im 2019-11-21 15:48
Oncologists vow to fight cancer through precision medicine by Jeong Sae-im 2019-11-21 14:28
Vivozon’s acquisition of Lumimicro may aim at backdoor listing by Jeong Sae-im 2019-11-20 14:44
Back to Top